Immunomedics Shares Up ~20% Over Last 2 Sessions; Several Execs/Insiders Filed Form 4's Showing Purchase Of 2.8M Shares, Including 1.325M Shares Via venBio Advisor; Stock Has Been Rangebound Between $10 And $12.50 Since Reporting Q1 Earnings On Nov. 9